Milestones affirmFlexsys' leadership in sustainability, from top 1% recognition to credible near-term and net-zero emissions reduction targets, and a commitment to 100% sustainable materials by 2040. Flexsys, a global leader in tire additives and solutions, has announced two major milestones in its sustainability journey. The company has been awarded the Platinum medal by EcoVadis in […]

PaceZero Capital Partners(“PaceZero”) announced today that it has provided Assembly Corp. (“Assembly”) with a $5 million credit facility. The funding will support Assembly as it delivers on its portfolio of development projects across the Greater Toronto Area. https://mma.prnewswire.com/media/2801104/PaceZero_Capital_Partners_Assembly_secures__5_million_Credit_Fac.jpg “Canada needs to increase the availability of quality, affordable homes,” said Jordan Peckham, Founder and CEO of

Creating the industry's first Agentic AI-Powered Client-Tailored intelligence Dataminr, the leader in AI-powered real-time event, threat & risk intelligence, today announced its intent to acquire ThreatConnect, a premier intelligence management platform for contextualizing and prioritizing threats across internal client data environments. The transaction values ThreatConnect at $290 million. https://mma.prnewswire.com/media/2576710/Dataminr_Logo_Logo_V1.jpg The fusion of Dataminr's leading AI

d'Esparbes to lead Antheia's financial strategy as the company continues its global expansionand commercialization Antheia, the pharmaceutical ingredient manufacturer transforming essential medicine supply chains, today announced the appointment of Eric d'Esparbes as Chief Financial Officer. d'Esparbes will oversee Antheia's financial strategy and operations as the company advances its next phase of commercialization and unlocks its

Flex (NASDAQ: FLEX) today announced that its sites in Manaus, Brazil, and our plastics operations in Guadalajara, Mexico, each received an Excellence Award from the Association for Manufacturing Excellence (AME), demonstrating global leadership in continuous improvement and operational excellence. These recognitions bring the total number of Flex sites honored by AME to six, with previous

Bar None Auction, a leading industrial and heavy equipment auction company headquartered in Sacramento, has been awarded the California Department of Transportation (Caltrans) contract to manage the statewide sale of surplus road maintenance and fleet equipment. https://mma.prnewswire.com/media/2799472/Bar_None_Auction_Delivery_of_service_trucks_to_be_sold_at_auction.jpg With thousands of new fleet vehicles and pieces of equipment purchased by the State each year, the older

Oracle Health and Life Sciences and Baylor College of Medicine today announced they will collaborate toadvance research and clinical insights into alcohol-related liver disease (ALD), one of the fastest-growing causes of liver-related illness and mortality in the United States. https://mma.prnewswire.com/media/1766551/Oracle_Logo_Logo.jpg Through this collaboration, Baylor College of Medicine plans to leverage Oracle Health's AI data platform

Onkos Surgical, a leading provider of innovative solutions for complex orthopaedic procedures, announced that it has recently received a 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its ELEOS Proximal Tibia with NanoCept Antibacterial Technology. This marks the first 510(k) clearance for the NanoCept Antibacterial Technology since the original De Novo authorization

Designworks Collective, a leading lifestyle design house and portfolio of curated brands, today announced the acquisition of Oré Originals, the California-based company behind the beloved Sugarbooger children's line and Speckle & Spot pet collection. This strategic move expands Designworks Collective's reach into two dynamic growth categories, children's products and pet accessories further strengthening its position

Avant Technologies Inc. (OTCQB: AVAI) (“Avant” or the “Company”) and global biotechnology firm, Austrianova, today announced the official launch of their joint venture, Klothonova LLC, and its groundbreaking Klotho development program. This initiative aims to engineer a genetically modified cell line that overexpresses the Klotho protein, paving the way for innovative cell-based therapies to combat